Other Viruses Citation List: August 15 - August 28, 2014

Hepatitis B Virus

1. Inhibition of Hepatitis B Virus Replication by SAMHD1. Chen, Z., M. Zhu, X. Pan, Y. Zhu, H. Yan, T. Jiang, Y. Shen, X. Dong, N. Zheng, J. Lu, S. Ying, and Y. Shen. Biochemical and Biophysical Research Communications, 2014. 450(4): p. 1462-1468. PMID[25019997].

[PubMed]. OV_0815-082814.

2. In Silico Analysis and Experimental Validation of Azelastine Hydrochloride (N4) Targeting Sodium Taurocholate Co-transporting Polypeptide (NTCP) in HBV Therapy. Fu, L.L., J. Liu, Y. Chen, F.T. Wang, X. Wen, H.Q. Liu, M.Y. Wang, L. Ouyang, J. Huang, J.K. Bao, and Y.Q. Wei. Cell Proliferation, 2014. 47(4): p. 326-335. PMID[24965018].

[PubMed]. OV_0815-082814.

3. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates in vivo. Lin, S.R., H.C. Yang, Y.T. Kuo, C.J. Liu, T.Y. Yang, K.C. Sung, Y.Y. Lin, H.Y. Wang, C.C. Wang, Y.C. Shen, F.Y. Wu, J.H. Kao, D.S. Chen, and P.J. Chen. Molecular Therapy - Nucleic Acids, 2014. 3: p. e186. PMID[25137139].

[PubMed]. OV_0815-082814.

Hepatitis C Virus

4. Design and Synthesis of Lactam-thiophene Carboxylic acids as Potent Hepatitis C Virus Polymerase Inhibitors. Barnes-Seeman, D., C. Boiselle, C. Capacci-Daniel, R. Chopra, K. Hoffmaster, C.T. Jones, M. Kato, K. Lin, S. Ma, G. Pan, L. Shu, J. Wang, L. Whiteman, M. Xu, R. Zheng, and J. Fu. Bioorganic & Medicinal Chemistry Letters, 2014. 24(16): p. 3979-3985. PMID[24986660].

[PubMed]. OV_0815-082814.

5. 2-Alkyloxazoles as Potent and Selective PI4KIIIbeta Inhibitors Demonstrating Inhibition of HCV Replication. Keaney, E.P., M. Connolly, M. Dobler, R. Karki, A. Honda, S. Sokup, S. Karur, S. Britt, A. Patnaik, P. Raman, L.G. Hamann, B. Wiedmann, and M.J. LaMarche. Bioorganic & Medicinal Chemistry Letters, 2014. 24(16): p. 3714-3718. PMID[25065492].

[PubMed]. OV_0815-082814.

6. Suppression of Hepatitis C Virus Replication by Cyclin-dependent Kinase Inhibitors. Munakata, T., M. Inada, Y. Tokunaga, T. Wakita, M. Kohara, and A. Nomoto. Antiviral Research, 2014. 108: p. 79-87. PMID[24893207].

[PubMed]. OV_0815-082814.

7. 2-Aminobenzoxazole Ligands of the Hepatitis C Virus Internal Ribosome Entry Site. Rynearson, K.D., B. Charrette, C. Gabriel, J. Moreno, M.A. Boerneke, S.M. Dibrov, and T. Hermann. Bioorganic & Medicinal Chemistry Letters, 2014. 24(15): p. 3521-3525. PMID[24930829].

[PubMed]. OV_0815-082814.

Herpes Simplex Virus 2

8. Tannic acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection. Orlowski, P., E. Tomaszewska, M. Gniadek, P. Baska, J. Nowakowska, J. Sokolowska, Z. Nowak, M. Donten, G. Celichowski, J. Grobelny, and M. Krzyzowska. PLoS One, 2014. 9(8): p. e104113. PMID[25117537].

[PubMed]. OV_0815-082814.

Citations from the ISI Web of Knowledge Listings for O.V.

9. Syntheses of 4 '-Spirocyclic phosphono-nucleosides as Potential Inhibitors of Hepatitis C Virus NS5B Polyinerase. Dang, Q., Z.B. Zhang, S.S. He, Y.H. Liu, T.Q. Chen, S. Bogen, V. Girijavallabhan, D.B. Olsen, and P.T. Meinke. Tetrahedron Letters, 2014. 55(31): p. 4407-4409. ISI[000339695700029].

[WOS]. OV_0815-082814.

10. Broad-spectrum Allosteric Inhibition of Herpesvirus Proteases. Gable, J.E., G.M. Lee, P. Jaishankar, B.R. Hearn, C.A. Waddling, A.R. Renslo, and C.S. Craik. Biochemistry, 2014. 53(28): p. 4648-4660. ISI[000339462800015].

[WOS]. OV_0815-082814.

11. Targeted Delivery of siRNA against Hepatitis B Virus by preS1 Peptide Molecular Ligand. Huang, W.J., X. Li, M. Yi, S.F. Zhu, and W.X. Chen. Hepatology Research, 2014. 44(8): p. 897-906. ISI[000339951200010].

[WOS]. OV_0815-082814.

12. Anti-Hepatitis C Virus Activity of Crude Extract and Fractions of Entada africana in Genotype 1b Replicon Systems. Tietcheu, B.R.G., G. Sass, N.F. Njayou, P. Mkounga, G. Tiegs, and P.F. Moundipa. American Journal of Chinese Medicine, 2014. 42(4): p. 853-868. ISI[000339653000006].

[WOS]. OV_0815-082814.